Full-Time

Senior Account Manager

Cell Signaling Technology

Cell Signaling Technology

1,001-5,000 employees

Antibody development and validated research tools

Compensation Overview

$110k - $182k/yr

+ 401(k) match

San Francisco, CA, USA

Remote

Travel approximately 20–30% domestically and internationally.

Bachelor's

Category
Sales & Account Management (1)
Required Skills
Sales
Forecasting
CRM
Salesforce

Get referred to Cell Signaling Technology

See people who can refer or advise you

Requirements
  • A Bachelor's degree in Life Sciences or a related field is required.
  • At least 5 years of life science sales experience is required, with strong emphasis on biopharma, contract research organizations, or translational and early clinical research environments.
  • Experience selling to accounts with strict internal assay validation, reproducibility, and documentation requirements is required.
  • Ability to sell complex scientific solutions into cell and gene therapy, immunology, or neuroscience sectors is required.
  • Practical experience with antibody-based applications in characterization or clinical workflows, including immunohistochemistry, flow cytometry, enzyme-linked immunosorbent assay, or high-content imaging, is required.
  • Strong understanding of drug development, translational research, and preclinical laboratory processes is required.
  • Ability to navigate complex stakeholder environments, including laboratory directors, screening groups, and procurement functions, is required.
  • Proficiency with customer relationship management systems, specifically Salesforce, is required.
  • Ability to travel regularly within the territory and willingness to travel approximately 20–30% domestically and internationally is required.
  • Ability to perform repetitive motions with the wrists, hands, and fingers is required.
  • Ability to extend hands and arms in any direction to access materials, equipment, or a keyboard is required.
  • Ability to sit for long periods is required.
  • Ability to view and read information from a computer monitor, reports, and documents is required.
  • Ability to safely lift and carry 25 pounds is required.
Responsibilities
  • Drive territory revenue growth by expanding the core portfolio across translational research and early-stage clinical workflows in immunology, neurodegeneration, and oncology.
  • Manage and expand key accounts across biopharma and contract research organizations using a consultative, solution-based approach tailored to preclinical and early clinical evaluation phases.
  • Engage laboratory leadership, translational scientists, and validation and quality teams to support product adoption and long-term partnerships.
  • Identify and capture opportunities within the CAR-T, TCR-T, and cell therapy pipeline, positioning early-phase clinical and good manufacturing practice products where lot-to-lot antibody consistency is a critical regulatory requirement.
  • Forecast sales, maintain pipeline visibility, and drive cross-selling and upselling of high-consistency solutions across account pipelines.
  • Partner with internal teams to develop proposals, pricing strategies, and contracts aligned with institutional purchasing and documentation processes.
  • Build and maintain strategic relationships with translational scientists, laboratory directors, and research quality stakeholders.
  • Advise customers on product validation, assay reproducibility, documentation standards, and early-stage compliance considerations.
  • Support customers in product selection to align with internal validation and characterization standards.
  • Anticipate customer needs and provide timely, technically sound responses.
  • Partner with Sales, Product Management, Marketing, Research and Development, and Quality teams to support commercialization and account engagement strategies.
  • Share customer insights on translational workflows and validation expectations to inform product positioning.
  • Coordinate with technical and application scientists to ensure solutions meet rigorous evaluation standards and are fit for purpose.
  • Align global and regional teams on territory account strategies and commitments.
  • Identify opportunities in emerging translational applications, expanded workflows, and regulated research spaces.
  • Represent the company at industry conferences, scientific symposia, and relevant regional events.
  • Provide strategic input into portfolio and commercial planning based on evolving market trends and validation requirements.
  • Maintain accurate account records, contracts, and documentation in compliance with company policies and standards.
  • Manage expenses and report performance metrics aligned with commercial objectives.
Desired Qualifications
  • An advanced degree is preferred.
  • Familiarity with good practice frameworks is preferred.
Cell Signaling Technology

Cell Signaling Technology

View

Cell Signaling Technology (CST) provides antibodies and related research products for scientists, especially in cancer research. Its main offering is antibodies that are thoroughly validated for multiple experimental applications, ensuring reliability across experiments. CST’s antibodies are produced by Ph.D.-level scientists who also deliver technical guidance and support to researchers to help achieve dependable results. The company differentiates itself through its strong emphasis on validation, quality control, and hands-on scientific support from its own researchers, operating with a family-owned, research-institute mindset rather than purely as a generic supplier. CST’s goal is to help researchers obtain accurate, reproducible data by supplying validated antibodies and expert methods guidance for use in the lab.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Danvers, Massachusetts

Founded

1999

Get referred to Cell Signaling Technology

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Quantum-Si and CST partnered June 2026 to validate PTM analysis on Proteus.
  • CST and MJFF are developing Parkinson's antibodies, expanding disease-targeted reagent demand.
  • Nordic Biosite began exclusive Nordic distribution for CST G4S Linker antibodies in August 2026.

What critics are saying

  • CST sells research-use-only reagents; a single validation miss destroys trust fast.
  • Spatial-biology rivals compress CST's mid-plex advantage as panels standardize.
  • If citation leadership fades, CST's antibody brand moat collapses and pricing power erodes.

What makes Cell Signaling Technology unique

  • CST remains scientist-owned and runs a 600-plus employee antibody platform from Danvers.
  • CiteAb named CST 2026 Phospho Antibody Supplier of the Year.
  • CST pairs validated antibodies with SignalStar multiplex IHC and PTM analysis partnerships.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Company Match

Tuition Reimbursement

Unlimited Paid Time Off

Parental Leave

Employee Assistance Program

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

27%

1 year growth

27%

2 year growth

27%
Nordic Biosite
Aug 19th, 2026
Nordic Biosite is the exclusive Nordic distributor for CST's G4S Linker Rabbit Monoclonal antibodies.

Nordic Biosite is the exclusive Nordic distributor for CST's G4S Linker Rabbit Monoclonal antibodies. news August 19 2026 Nordic Biosite is excited to announce its exclusive distribution partnership across Sweden, Denmark, Norway, and Finland for Cell Signaling Technology's (CST) premier line of Pre-GMP-grade G4S Linker antibodies. Chimeric Antigen Receptor (CAR) cell therapy is moving at a rapid pace, but researchers often struggle with reliable tracking reagents during early-phase development. This exclusive partnership changes that by bringing CST's premier translational tools directly to the Nordic region. Nordic Biosite is fully authorized to distribute the following early-access, Pre-GMP-grade products: * G4S Linker (E7O2V) Rabbit Monoclonal Antibody (PE Conjugate) * G4S Linker (E7O2V) Rabbit Monoclonal Antibody (Biotin Conjugate) By keeping these high-demand reagents in local stock, Nordic Biosite eliminates long international shipping delays, ensuring your lab has immediate access to the exact tools you need to advance your cell therapy research. News & articles. News August 13 2026 News July 31 2026 News June 30 2026 News August 19 2026 News August 18 2026 News August 13 2026 News July 31 2026 News June 30 2026 News August 19 2026 News August 18 2026

BioSpace
Mar 26th, 2025
Leveragen Partners with Cell Signaling Technology to Advance Reagent Antibody Innovation with Proprietary Nanobody Technology

Leveragen partners with Cell Signaling Technology to advance reagent antibody innovation with proprietary nanobody Technology.

Cell Signaling Technology
Feb 12th, 2025
Does It Really Work? How InTraSeq(TM) Integrates Transcriptomic, Proteomic, & Intracellular Interaction Data

Cell Signaling Technology, Inc. is thrilled to announce the winners of the 5th annual Rising Black Scientists Awards!

Cell Signaling Technology
Oct 24th, 2023
Cell Signaling Technology and The Michael J. Fox Foundation Partner to Develop High-Quality Antibody Tools for Parkinson's Disease Research

Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, announced their partnership with The Michael J. Fox Foundation for Parkinson's Research (MJFF) today to identify and develop high-quality monoclonal antibodies for promising Parkinson's disease (PD) targets.

Compsmag
Sep 20th, 2023
Green Chemistry Education: Cell Signaling Technology and Beyond Benign Join Forces for a Sustainable Future!

According to a recent announcement, Cell Signaling Technology (CST), a prominent life sciences discovery technology company, has partnered with Beyond Benign, a global green chemistry education nonprofit.